TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/23 20:00 | 8/1/23 | SURF | Surface Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ross Robert W. | MA | O | CEO | S | -16 | 0.9400 | 0 | -17 | -17 | 83 | D | ||||||||||||||
8/5/22 20:00 | 8/3/22 | SURF | Surface Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ross Robert W. | MA | O | CEO | S | -18 | 1.72 | 0 | -11 | -10 | 100 | D | ||||||||||||||
1/14/22 20:30 | 7/21/21 | SURF | Surface Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ross Robert W. | MA | O | CEO | S | -204 | 6.10 | 0 | -34 | -38 | 55 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |